| Bioactivity | PF-04885614 is a potent NaV1.8 inhibitor, extracted from patent US2018328915. PF-04885614 has potential for neurological and neurodevelopmental diseases treatment[1]. | ||||||||||||
| Name | PF-04885614 | ||||||||||||
| CAS | 1480833-70-2 | ||||||||||||
| Formula | C13H14F3N3O | ||||||||||||
| Molar Mass | 285.26 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Brady MAHER, et al. Treatment of Neurological and Neurodevelopmental Diseases and Disorders Associated with Aberrant Ion Channel Expression and Activity. US20180328915A1. |